Search Results 271-280 of 16530 for ������������KA���:ZA31���24������ ���������������������������������

  1. Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis - Mayo Clinic

    About this study. The purpose of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm ...

  2. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Cediranib maleate and olaparib may stop the growth of tumor cells by blocking enzymes needed for cell growth. Drugs used in chemotherapy work in different ways ...

  3. Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer - Mayo Clinic

    Cabozantinib-s-malate and sunitinib malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known ...

  4. Siegel TAVR in Aortic Severe Stenosis - Clinical Trials

    Life expectancy < 24 months due to associated non-cardiac co-morbid conditions; Other medical, social, or psychological conditions that in the opinion of an ...

  5. Publications - Aqsa A. Khan, M.D. - Mayo Clinic

    Lee YS, Khan AA. Financial Toxicity for Female Patients with Urinary Incontinence. Curr Urol Rep. 2023 Jan; 24(1):33-39. Epub 2022 Dec 17.

  6. A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors - Mayo Clinic

    Jacksonville, Florida: 24-003633; Rochester, Minnesota: 24-003633. NCT ID: NCT05954312. Sponsor Protocol Number: VVD-130037-001. About this study. The purpose ...

  7. Publications - Daniel L. Price, M.D. - Mayo Clinic

    ... KA, Fuentes Bayne HE, Rwigema JCM, Patel SH ... 2025; 36(1):14-24. Epub 2024 Aug 09. Calcano GA ... 2021 Jul; 82 (Suppl 3):e138-e147 Epub 2020 Jan 24

  8. Publications - David Karow, M.D. - Mayo Clinic

    2020 Feb 11; 117 (6):3053-3062 Epub 2020 Jan 24. View PubMed; Shomorony I ... KE, Brar P, Kahn AM, Spector TD, Caskey CT, Venter JC, Karow DS, Kirkness ...

  9. CAT Effect on Anxiety during In-office Otolaryngology Procedures - Mayo Clinic

    Jacksonville, Florida: 24-007139. About this study. The purpose of this study is to use Canine Assisted Therapy (CAT) in patients undergoing office procedures ...

  10. A Study to Evaluate the Safety and Effectiveness of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy - Mayo Clinic

    The study will assess proteinuria by 24-hour urine protein excretion (UPE) in g/day at 36 weeks from beginning of treatment. Participation eligibility.